testosterone undecanoate has been researched along with Diabetes Mellitus, Type 1 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albareda, M; Chillarón, JJ; Colom, C; Fernández-Miró, M; Flores Le-Roux, JA; Fontserè, S; Pedro-Botet, J; Vila, L | 1 |
1 trial(s) available for testosterone undecanoate and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Testosterone undecanoate improves lipid profile in patients with type 1 diabetes and hypogonadotrophic hypogonadism.
Topics: Adult; Diabetes Mellitus, Type 1; Female; Humans; Hypogonadism; Lipid Metabolism; Lipids; Male; Metabolic Syndrome; Middle Aged; Spain; Testosterone | 2016 |